durvalumab (MEDI4736)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for durvalumab (MEDI4736), covering 2017-10-23 to 2025-11-25. Get the full timeline:
Most recent: Clinical Trial Update: Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers [Phase 1]